Globeimmune Inc
OTC:GBIM
Globeimmune Inc
Other Operating Expenses
Globeimmune Inc
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Globeimmune Inc
OTC:GBIM
|
Other Operating Expenses
-$2.4m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Operating Expenses
$179m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Operating Expenses
-$791m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Operating Expenses
$51.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Operating Expenses
-$13.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Globeimmune Inc's Other Operating Expenses?
Other Operating Expenses
-2.4m
USD
Based on the financial report for Dec 31, 2015, Globeimmune Inc's Other Operating Expenses amounts to -2.4m USD.
What is Globeimmune Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
38%
Over the last year, the Other Operating Expenses growth was 32%. The average annual Other Operating Expenses growth rates for Globeimmune Inc have been 38% over the past three years .